PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8454756

Acute cholangitis: CT evaluation.

E J Balthazar·B A Birnbaum·M Naidich
View original source ↗Export metadata ↓

Abstract

The CT findings of 23 patients with proven acute ascending cholangitis were retrospectively evaluated. Computed tomography confirmed the clinical diagnosis and detected the site and etiology of the obstructive process in the majority of patients. Biliary dilatation consistent with the clinical suspicion of acute cholangitis was present in 18 patients (78%), the level of the obstruction was detected in 15 patients, and the etiology of the obstructive process was visualized in 14 cases. Five patients presented with air in the biliary tree and three patients had liver abscesses. There was no good correlation established between jaundice, biliary infection, and the presence or degree of biliary dilatation. Biliary obstruction and acute cholangitis can develop before biliary dilatation is detected. In addition, CT showed limitations in establishing the etiology of the obstructive process, particularly in failing to detect 7 of 17 cases of cholesterol biliary stones.

Explore related subjects

Acute DiseaseAdultAgedAged, 80 and overBacterial InfectionsCholangitisCholestasisDilatation, PathologicFemaleGallstonesHumansJaundiceLiver AbscessMaleMiddle AgedPancreatic NeoplasmsRetrospective StudiesTomography, X-Ray ComputedJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E J Balthazar, B A Birnbaum, M Naidich. Acute cholangitis: CT evaluation.. https://doi.org/10.1097/00004728-199303000-00020

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Hallucinations in the acute schizophrenic-type psychosis: effects of gender and age of illness onset.

Our objective was to test the hypothesis that gender, the age of illness onset, or the interaction between these two variables, would distinguish acutely ill schizophrenic and schizoaffective patients who hallucinated from those who did not. Hallucinatory experiences were measured by the hallucination item of the Brief Psychiatric Rating Scale in a sample of 160 drug-free inpatients admitted for the treatment of an acute episode. Patients were categorized as either non-hallucinators or hallucinators. An additional analysis included only those who had 'severe' hallucinations (i.e., score > or = 5). Female gender, but not age of onset, predicted a higher frequency of hallucinations (irrespective of degree of severity) in the total sample, but specifically in the schizophrenic patients. These results indicate that there may be gender differences in the propensity to experience hallucinations during the acute schizophrenic episode.

Acute Disease↗
PubMed1999

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Internal tandem duplication of the FLT3 gene and point mutations of the N-RAS gene are the most frequent somatic mutations causing aberrant signal-transduction in acute myeloid leukemia (AML). However, their prognostic importance is unclear. In this study, their prognostic significance was analyzed in 201 newly diagnosed patients with de novo AML except acute promyelocytic leukemia. Three patients had mutations in both genes, 43 had only the FLT3 gene mutation, 25 had only the N-RAS gene mutation, and 130 had neither. These mutations seemed to occur independently. Both mutations were related to high peripheral white blood cell counts, and the FLT3 gene mutation was infrequently observed in the French-American-British (FAB)-M2 type. AML cases with wild FLT3/mutant N-RAS had a lower complete remission (CR) rate than those with wild FLT3/wild N-RAS, whereas the presence of mutant FLT3 did not affect the CR rate. Univariate analysis showed that unfavorable prognostic factors for overall survival were age 60 years or older (P =.0002), cytogenetic data (P =.002), FAB types other than M2 (P =.002), leukocytosis over 100 +/- 10(9)/L (P =.003), and the FLT3 gene mutation (P =.004). However, the N-RAS gene mutation was only a marginal prognostic factor (P =.06). For the subjects under 60 years old, multivariate analysis showed that the FLT3 gene mutation was the strongest prognostic factor (P =.008) for overall survival. The FLT3 gene mutation, whose presence is detectable only by genomic polymerase chain reaction amplification and gel electrophoresis, might serve as an important molecular marker to predict the prognosis of patients with AML.

Acute Disease↗